puast-attb vector Search Results


puast-attb vectors  (BestGene Inc)
90
BestGene Inc puast-attb vectors
Puast Attb Vectors, supplied by BestGene Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/puast-attb+vector/puast+attb+vector/pmc07401224-75-2-19
Average 90 stars, based on 1 article reviews
puast-attb vectors - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
puastattb vectors  (BestGene Inc)
90
BestGene Inc puastattb vectors
Puastattb Vectors, supplied by BestGene Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/puast-attb+vector/puastattb+vector/pmc04754048-354-8-22
Average 90 stars, based on 1 article reviews
puastattb vectors - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
expression vectors puast-attb-rfa-mcherry  (Marburg GmbH)
90
Marburg GmbH expression vectors puast-attb-rfa-mcherry
Expression Vectors Puast Attb Rfa Mcherry, supplied by Marburg GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/puast-attb+vector/expression+vectors+puast+attb+rfa+mcherry/pmc07438013-256-9-20
Average 90 stars, based on 1 article reviews
expression vectors puast-attb-rfa-mcherry - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
drosophila transgene vector puast-attb  (Genetivision Corporation)
90
Genetivision Corporation drosophila transgene vector puast-attb
Glycogen phosphorylase (GlyP) phosphorylation is required for longevity conferred by mutation of dilp2 . Survival calculated from life tables based on estimated Gompertz mortality parameters for UAS-GlyP expression in a dilp2 mutant background with transgenes driven by systemic DaGS-Gal4. Gompertz mortality scale (l, frailty) parameters of <t>transgene</t> expression genotypes were adjusted for the impact of RU alone upon mortality estimated from control genotypes. (A) Overexpression of wild-type GlyP does not extend longevity (Cox hazard analysis, χ 2 = 0.1, p = 0.76), (B) expression of GlyP S15A decreases lifespan (Cox hazard analysis, χ 2 = 24.2, p < 0.0001), and (C) expression of GlyP S15D does not extend longevity (Cox hazard analysis, χ 2 = 1.2, p = 0.28). Each genotype cohort n = 351–361 adults.
Drosophila Transgene Vector Puast Attb, supplied by Genetivision Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/puast-attb+vector/drosophila+transgene+vector+puast+attb/pmc05985746-200-11-19
Average 90 stars, based on 1 article reviews
drosophila transgene vector puast-attb - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
puast-attb-ccdc6-ret vectors  (BestGene Inc)
90
BestGene Inc puast-attb-ccdc6-ret vectors
Glycogen phosphorylase (GlyP) phosphorylation is required for longevity conferred by mutation of dilp2 . Survival calculated from life tables based on estimated Gompertz mortality parameters for UAS-GlyP expression in a dilp2 mutant background with transgenes driven by systemic DaGS-Gal4. Gompertz mortality scale (l, frailty) parameters of <t>transgene</t> expression genotypes were adjusted for the impact of RU alone upon mortality estimated from control genotypes. (A) Overexpression of wild-type GlyP does not extend longevity (Cox hazard analysis, χ 2 = 0.1, p = 0.76), (B) expression of GlyP S15A decreases lifespan (Cox hazard analysis, χ 2 = 24.2, p < 0.0001), and (C) expression of GlyP S15D does not extend longevity (Cox hazard analysis, χ 2 = 1.2, p = 0.28). Each genotype cohort n = 351–361 adults.
Puast Attb Ccdc6 Ret Vectors, supplied by BestGene Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/puast-attb+vector/puast+attb+ccdc6+ret+vectors/pmc05858711-440-3-8
Average 90 stars, based on 1 article reviews
puast-attb-ccdc6-ret vectors - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
puast_attb vector  (Genentech inc)
90
Genentech inc puast_attb vector
Glycogen phosphorylase (GlyP) phosphorylation is required for longevity conferred by mutation of dilp2 . Survival calculated from life tables based on estimated Gompertz mortality parameters for UAS-GlyP expression in a dilp2 mutant background with transgenes driven by systemic DaGS-Gal4. Gompertz mortality scale (l, frailty) parameters of <t>transgene</t> expression genotypes were adjusted for the impact of RU alone upon mortality estimated from control genotypes. (A) Overexpression of wild-type GlyP does not extend longevity (Cox hazard analysis, χ 2 = 0.1, p = 0.76), (B) expression of GlyP S15A decreases lifespan (Cox hazard analysis, χ 2 = 24.2, p < 0.0001), and (C) expression of GlyP S15D does not extend longevity (Cox hazard analysis, χ 2 = 1.2, p = 0.28). Each genotype cohort n = 351–361 adults.
Puast Attb Vector, supplied by Genentech inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/puast-attb+vector/puast+attb+vector/pmc08011352-328-9-12
Average 90 stars, based on 1 article reviews
puast_attb vector - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
puast-attb vector  (Genetic Services Inc)
90
Genetic Services Inc puast-attb vector
Glycogen phosphorylase (GlyP) phosphorylation is required for longevity conferred by mutation of dilp2 . Survival calculated from life tables based on estimated Gompertz mortality parameters for UAS-GlyP expression in a dilp2 mutant background with transgenes driven by systemic DaGS-Gal4. Gompertz mortality scale (l, frailty) parameters of <t>transgene</t> expression genotypes were adjusted for the impact of RU alone upon mortality estimated from control genotypes. (A) Overexpression of wild-type GlyP does not extend longevity (Cox hazard analysis, χ 2 = 0.1, p = 0.76), (B) expression of GlyP S15A decreases lifespan (Cox hazard analysis, χ 2 = 24.2, p < 0.0001), and (C) expression of GlyP S15D does not extend longevity (Cox hazard analysis, χ 2 = 1.2, p = 0.28). Each genotype cohort n = 351–361 adults.
Puast Attb Vector, supplied by Genetic Services Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/puast-attb+vector/puast+attb+vector/pmc06944410-40-20-31
Average 90 stars, based on 1 article reviews
puast-attb vector - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
puast-attb vector  (GenScript corporation)
90
GenScript corporation puast-attb vector
Glycogen phosphorylase (GlyP) phosphorylation is required for longevity conferred by mutation of dilp2 . Survival calculated from life tables based on estimated Gompertz mortality parameters for UAS-GlyP expression in a dilp2 mutant background with transgenes driven by systemic DaGS-Gal4. Gompertz mortality scale (l, frailty) parameters of <t>transgene</t> expression genotypes were adjusted for the impact of RU alone upon mortality estimated from control genotypes. (A) Overexpression of wild-type GlyP does not extend longevity (Cox hazard analysis, χ 2 = 0.1, p = 0.76), (B) expression of GlyP S15A decreases lifespan (Cox hazard analysis, χ 2 = 24.2, p < 0.0001), and (C) expression of GlyP S15D does not extend longevity (Cox hazard analysis, χ 2 = 1.2, p = 0.28). Each genotype cohort n = 351–361 adults.
Puast Attb Vector, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/puast-attb+vector/puast+attb+vector/pm37909961-57-16-19
Average 90 stars, based on 1 article reviews
puast-attb vector - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Glycogen phosphorylase (GlyP) phosphorylation is required for longevity conferred by mutation of dilp2 . Survival calculated from life tables based on estimated Gompertz mortality parameters for UAS-GlyP expression in a dilp2 mutant background with transgenes driven by systemic DaGS-Gal4. Gompertz mortality scale (l, frailty) parameters of transgene expression genotypes were adjusted for the impact of RU alone upon mortality estimated from control genotypes. (A) Overexpression of wild-type GlyP does not extend longevity (Cox hazard analysis, χ 2 = 0.1, p = 0.76), (B) expression of GlyP S15A decreases lifespan (Cox hazard analysis, χ 2 = 24.2, p < 0.0001), and (C) expression of GlyP S15D does not extend longevity (Cox hazard analysis, χ 2 = 1.2, p = 0.28). Each genotype cohort n = 351–361 adults.

Journal: Frontiers in Endocrinology

Article Title: Drosophila Insulin-Like Peptides DILP2 and DILP5 Differentially Stimulate Cell Signaling and Glycogen Phosphorylase to Regulate Longevity

doi: 10.3389/fendo.2018.00245

Figure Lengend Snippet: Glycogen phosphorylase (GlyP) phosphorylation is required for longevity conferred by mutation of dilp2 . Survival calculated from life tables based on estimated Gompertz mortality parameters for UAS-GlyP expression in a dilp2 mutant background with transgenes driven by systemic DaGS-Gal4. Gompertz mortality scale (l, frailty) parameters of transgene expression genotypes were adjusted for the impact of RU alone upon mortality estimated from control genotypes. (A) Overexpression of wild-type GlyP does not extend longevity (Cox hazard analysis, χ 2 = 0.1, p = 0.76), (B) expression of GlyP S15A decreases lifespan (Cox hazard analysis, χ 2 = 24.2, p < 0.0001), and (C) expression of GlyP S15D does not extend longevity (Cox hazard analysis, χ 2 = 1.2, p = 0.28). Each genotype cohort n = 351–361 adults.

Article Snippet: Wild-type, S15A, and S15D GlyP coding sequences were sub-cloned into the Drosophila transgene vector pUAST-attB and were submitted to GenetiVision Corporation (Houston, TX, USA) for transgene embryo injection and stock generation.

Techniques: Mutagenesis, Expressing, Over Expression